About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Meta-analysis Fail to Reveal Funding

by Sheela Philomena on March 10, 2011 at 10:12 AM
Font : A-A+

 Meta-analysis Fail to Reveal Funding

In meta-analysis information on funding sources and conflict of interests by the study authors are rarely disclosed, says report in the Journal of the American Medical Association. Meta-analysis is a combination of a group of small studies in a particular area of research and this analysis aids to form treatment guidelines. The study authors who work on a research work may have financial ties to the drug companies that undergo trials.

"Meta-analyses are cited more than any other study design and prioritized in grading evidence for practice guidelines," but conflicts on interest (COIs) are often left out, said the study.

Advertisement

"Without documentation in meta-analyses of COIs from included RCTs (randomized controlled trials), users of meta-analyses may not have access to important information that could influence their evaluation of the risk of bias in the evidence reported."

Researchers reviewed 29 meta-analyses, which spanned 509 trials and appeared in major medical publications such as the Lancet, the British Medical Journal and the Journal of the American Medical Association.
Advertisement

Of those 29 meta-analyses, only two reported the funding sources for the initial randomized trials, and none reported any author-industry ties.

However the smaller randomized trials had reported such ties: 62.5 percent reported their funding and of those, 68.9 percent were "funded in part or whole by the pharmaceutical industry," the study said.

Researchers found seven meta-analyses "where every single drug trial included was paid for, at least in part, by the maker of the drug or had investigators linked financially to drug makers," but just one disclosed those links.

"Consumers can be more confident that drugs actually work if there is at least one independent evaluation that confirms this," said lead author Brett Thombs at McGill University.

"When all existing studies are financially linked to drug makers, there is a risk that patients and their physicians may be misled."

Thombs and his co-authors are urging policy changes to require meta-analyses to report potential conflicts.

"Unless we require authors of meta-analyses to provide this information for consumers, it will be lost."

Source: AFP
Advertisement
Advertisement
Advertisement
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Meta-analysis Fail to Reveal Funding Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests